Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_assertion type Assertion NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_head.
- NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_assertion description "[In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_provenance.
- NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_assertion evidence source_evidence_literature NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_provenance.
- NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_assertion SIO_000772 15956284 NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_provenance.
- NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_assertion wasDerivedFrom befree-2016 NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_provenance.
- NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_assertion wasGeneratedBy ECO_0000203 NP499516.RA6Mw4y2V1R2cXh1RztBcrPM8xCrU5AU7wcxiVjLPFMUI130_provenance.